Jeff Mandelbaum Joins Imerjn Board
May 29 2014 - 6:00AM
Xumanii (DBA Imerjn) (OTCQB:XUII), announced that Jeffrey
Mandelbaum has become a member of the Board of Directors of the
Company. Jeff is an accomplished high technology executive who has
played key executive management roles for more than 25 years.
As a consultant, Jeff has provided advisory services focused on
strategy, sales and marketing management, business development, and
corporate finance services for leading private equity investors and
their portfolio companies including Warburg Pincus, Kleiner Perkins
Caufield & Byers, Sigma Partners, Baker Capital, and Draper
Atlantic.
Prior to becoming a consultant, Jeff was Vice President of Media
Systems Sales for Real Networks, Vice President of worldwide sales
at Commerce One, held several positions at Sybase, Inc. where
he was a member of the initial management team. In his position as
CEO and President of Sybase Financial Services, Inc. and was
responsible for worldwide customer and partner financing. Under
Jeff's leadership, Sybase Financial Services, Inc. closed over
$900,000,000 in financing transactions between 1990 and 1996.
Jeff supports several philanthropic organizations and has served
as a National Vice President of the Muscular Dystrophy Association.
Jeff is a graduate of the Executive Program in Business
Administration from the Columbia University Graduate School of
Business.
Imerjn CEO, Adam Radly, said, "We are very fortunate to have
Jeff join our board. His experience in helping small companies grow
into big companies will be invaluable and I'm looking forward to
working with him to build Imerjn."
Jeff Mandelbaum, said, "Imerjn has some very interesting
technology and intellectual property and I'm looking forward to
helping the team develop that technology further and grow the
Company."
About Imerjn
Imerjn (XUII), formerly known as Xumanii International Holdings
Corp is an early stage company that develops and sells mobile
software and hardware solutions. For more information please visit
the company website at: http://www.imerjn.com. Contact: Adam Radly,
info@imerjn.com.
Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995: Except for historical
information, the forward-looking matters discussed in this news
release are subject to certain risks and uncertainties which could
cause the Company's actual results and financial condition to
differ materially from those anticipated by the forward-looking
statements including, but not limited to, the Company's liquidity
and the ability to obtain financing, the timing of regulatory
approvals, uncertainties related to corporate partners or
third-parties, product liability, the dependence on third parties
for manufacturing and marketing, patent risk, copyright risk,
competition, and the early stage of products being marketed or
under development, as well as other risks indicated from time to
time in the Company's filings with the Securities and Exchange
Commission. The Company assumes no obligation to update or
supplement forward-looking statements that become untrue because of
subsequent events.
Imerjn (CE) (USOTC:IMJN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Imerjn (CE) (USOTC:IMJN)
Historical Stock Chart
From Apr 2023 to Apr 2024